Healio

FDA grants de novo clearance for endoscopic sleeve gastroplasty, bariatric revision devices

Please provide your email address to receive an email when new articles are posted on . The FDA has granted de novo authorization for Apollo Endosurgery to market its Apollo ESG and Apollo REVISE ...
Healio

Top 25 US insurers fail to provide coverage for intragastric balloon, endoscopic sleeve

Please provide your email address to receive an email when new articles are posted on . None of the largest U.S. insurers provide coverage for intragastric balloon or endoscopic sleeve gastroplasty.
Nasdaq

FDA Grants De Novo Marketing Authorization to Apollo Endosurgery for Apollo ESG(TM) and Apollo REVISE(TM), New Endoscopic Systems for Patients with Obesity

AUSTIN, TX / ACCESSWIRE / July 13, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, ...
Medscape

FDA Clears Endoscopic Devices for Sleeve Gastroplasty, Bariatric Revision

The US Food and Drug Administration (FDA) has cleared for marketing the first devices indicated for endoscopic sleeve gastroplasty (ESG) and endoscopic bariatric revision, according to the ...
Finanznachrichten

Apollo Endosurgery, Inc.: Apollo Endosurgery Completes Transition to European MDR Requirements for the OverStitch Systems, BIB and Orbera 365 intragastric balloons, and OverTube.

OverStitch has new indications for use statement under CE-Mark, including indications for defect closure, stent fixation, endoscopic sleeve gastroplasty and transoral outlet reduction AUSTIN, TX / ...
Yahoo Finance

Apollo Endosurgery Completes Transition to European MDR Requirements for the OverStitch Systems, BIB and Orbera 365 intragastric balloons, and OverTube.

OverStitch has new indications for use statement under CE-Mark, including indications for defect closure, stent fixation, endoscopic sleeve gastroplasty and transoral outlet reduction AUSTIN, TX / ...